Where the problem is most acute or will become acute.
The ones where we have the best connections (not China).
I don't care. Pre clinicals should have done immediately if only for the sake of achieving a better company valuation.

Clearly the market doesnt like the way Cydy is handling the Coronavirus opportunity (can't find a better word for now).